Insights and Updates

Discover our latest posts, insights, and updates on what we do and what we care about.

Doctor zhou

Excessive Immune Reactions Caused by Ipilimumab

Ipilimumab, also known as Y-drug or anti-CTLA4 monoclonal antibody, is a recombinant humanized monoclonal antibody developed by Bristol-Myers Squibb that binds to cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4). Since March 25, 2011, when the US FDA approved Yervoy (3 mg/kg) monotherapy for unresectable or metastatic melanoma, more…

Continue reading...
Doctor zhou

Cancer Risk in Lynch Syndrome

Lynch syndrome is a common autosomal dominant genetic disease resulting from germline mutations in DNA mismatch repair genes; it is also called HNPCC syndrome. The lifetime risk of colon cancer in Lynch patients is about 70–80%, and Lynch syndrome accounts for 2–4% of all colorectal…

Continue reading...